. The ROS responsible for this effect is not known. The present study focuses on superoxide (O 2 ·Ϫ ), hydrogen peroxide (H2O2), and hydroxyl radical (HO˙), each of which has been proposed as the signaling ROS. Feedback activation of mitoK ATP provides an ideal setting for studying endogenous ROS signaling. Respiring rat heart mitochondria were preincubated with ATP and diazoxide, together with an agent being tested for interference with this process, either by scavenging ROS or by blocking ROS transformations. The mitochondria were then assayed to determine whether or not the persistent phosphorylated open state was achieved. Dimethylsulfoxide (DMSO), dimethylformamide (DMF), deferoxamine, Trolox, and bromoenol lactone each interfered with formation of the ROS-dependent open state. Catalase did not interfere with this step. We also found that DMF blocked cardioprotection by both ischemic preconditioning and diazoxide. The lack of a catalase effect and the inhibitory effects of agents acting downstream of HO˙excludes H2O2 as the endogenous signaling ROS. Taken together, the results support the conclusion that the ROS message is carried by a downstream product of HO˙and that it is probably a product of phospholipid oxidation. mitochondria; cardioprotection; reactive oxygen species; KATP channels; cardiac ischemia; ROS signaling REACTIVE OXYGEN SPECIES (ROS) are second messengers of preconditioning (21) and have long been known to be required for cardioprotective signaling (3, 10, 18, 34, 43, 49) . The mechanism of increased ROS is reasonably well understood: signaling from the plasma membrane leads to opening of the mitochondrial ATP-sensitive K ϩ channel (mitoK ATP ; Ref. 19), and the increased K ϩ influx into the matrix causes an increase in ROS, which derive during normoxia from complex I of the respiratory chain (1).
REACTIVE OXYGEN SPECIES (ROS) are second messengers of preconditioning (21) and have long been known to be required for cardioprotective signaling (3, 10, 18, 34, 43, 49) . The mechanism of increased ROS is reasonably well understood: signaling from the plasma membrane leads to opening of the mitochondrial ATP-sensitive K ϩ channel (mitoK ATP ; Ref. 19) , and the increased K ϩ influx into the matrix causes an increase in ROS, which derive during normoxia from complex I of the respiratory chain (1) .
The ROS transformations that take place in mitochondria are summarized in Figs. 1 and 2. The primary ROS produced by the mitochondrial respiratory chain is superoxide (O 2 ·Ϫ ), which is formed by single-electron reduction of oxygen. The majority of O 2 ·Ϫ undergoes dismutation to hydrogen peroxide (H 2 O 2 ) both spontaneously and through the action of superoxide dismutases located in the matrix and the intermembrane space (7, 26, 33) . Much of the H 2 O 2 generated is reduced by the glutathione and thioredoxin reductase antioxidant systems, which prevent the emission of excess H 2 O 2 to the cytosol (42) . H 2 O 2 is also decomposed by catalase, which is present in the matrix of heart mitochondria. Some of the H 2 O 2 leads to formation of hydroxyl radical (HO˙) through the Fenton reaction of H 2 O 2 with transition metal ions (29) . The highly reactive HO˙oxidizes proteins and lipids in diffusion-limited reactions (27) . The consequences of ROS signaling for mitochondrial physiology are that two mitochondrial protein kinase-Cε (PKCε) are activated by oxidation of their thiol groups (28) . Activation of PKCε1, which is associated with mitoK ATP at the mitochondrial inner membrane, leads to opening of mitoK ATP (13, 25) . Activation of PKCε2 leads to inhibition of the mitochondrial permeability transition (MPT; Ref. 12) . Progress is being made in these areas and in the molecular identification of mitoK ATP (17) . However, the ROS responsible for activating these PKCεs in vitro or in vivo is still not known. Because the signaling ROS not only originates in mitochondria but also acts on mitochondria, it should be possible to narrow the search for the signaling ROS by studies on isolated rat heart mitochondria. The objective of these studies was to identify the point in the reaction sequence of ROS transformations at which the ROS signal is formed and, ultimately, to determine the identity of the ROS signal itself.
We previously described feedback activation of mitoK ATP , in which mitoK ATP opening by a K ATP channel opener leads to endogenous ROS formation and a persistent open state of mitoK ATP . The phenomenon was shown to involve PKCε1 and an inner membrane phosphorylation event (13) . This persistent open state of mitoK ATP is thought to be responsible for "memory," which is seen with all preconditioning (13) .
We employed a preincubation protocol to probe the feedback activation system for the identity of the signaling ROS. Diazoxide was used to induce mitoK ATP opening, which leads to endogenous ROS formation and activation of PKCε1. This process establishes the prolonged phosphorylation-dependent open state of mitoK ATP (13) . We then reisolated the mitochondria and probed them for this state by measuring the resulting steady-state mitochondrial matrix volume using the light-scattering technique (5, 11, 14, 20) . Agents or conditions that interfered with any step in the generation of the signaling ROS would prevent formation of the phosphorylation dependent open state. Two additional assays were carried out to eliminate agents that interfered either with mitoK ATP -dependent K procedures allowed identification of agents that specifically interfered with formation of the ROS signal.
The agents that were found to block formation of the ROS signal were dimethylsulfoxide (DMSO) and dimethylformamide (DMF), scavengers of HO˙and RȮ (2, 32); Trolox, a chain-breaking antioxidant and peroxyl radical scavenger (31); deferoxamine, an iron chelator (29, 41) We performed experiments on MPT in which diazoxide was used to induce inhibition of MPT via ROS activation of PKCε2 (12) . This effect was blocked by DMSO, also implicating a ROS signal downstream from HO˙. Finally, we found that the HO˙scavenger DMF blocked cardioprotection by ischemic preconditioning and diazoxide. Taken together, each of these results supports the conclusion that the ROS message is carried by a downstream product of hydroxyl radical (HO˙). The actions of BEL suggest a product of phospholipid oxidation.
RESEARCH DESIGN AND METHODS
Langendorff-perfused hearts. Hearts from male Sprague-Dawley rats (200 -240g) were perfused as previously described (15, 22, 37, 39) with Krebs-Henseleit buffer containing the following (in mM): 118 NaCl, 5.9 KCl, 1.75 CaCl 2, 1.2 MgSO4, 0.5 EDTA, 25 NaHCO3, 16.7 glucose at 37°C and pH 7.4 and gassed with 95% O2-5% CO2. Treatment protocols are described in Fig. 3 . Hearts were stabilized for 25 min with Krebs Henseleit buffer before treatment with buffer containing drugs or agents and then subjected to 25-min global ischemia followed by 2 h of reperfusion and measurement of infarct size. Ischemic preconditioning was established by two cycles of 5-min global ischemia followed by 5-min reperfusion before the index ischemia. Ischemic postconditioning was performed with six cycles of 10-s ischemia plus 10-s reperfusion (45) . Hearts were not paced, and mechanical performance was evaluated as the product of heart rate and left ventricular developed pressure and reported as a percentage of rate pressure product at stabilization, t ϭ 0. Infarct size was determined by the method of Ytrehus et al. (48) Fig. 3 . Isolated heart protocols. Hearts were perfused with buffer, as described in RESEARCH DESIGN AND METHODS. After 45 min of stabilization, hearts were subjected to 25 min global ischemia (GI), followed by 2 h of reperfusion (R) and, finally, processing for infarct size estimation. Protocol for ischemic reperfusion (IR) without additional treatment is labeled "IR." Ischemic preconditioning (IPC) was established by 5-min global ischemia followed by 10-min reperfusion before the index ischemia. Diazoxide (Dzx; 50 M) was perfused for 5 min, followed by 10-min reperfusion with buffer before the index ischemia. Dimethylformamide (DMF; 1% vol/vol) was administered 5 min before the first IPC ischemia and before Dzx; it was continued for 5 min after these treatments and this was followed by 5-min reperfusion with buffer before the index ischemia.
hearts were removed for mitochondrial isolation exactly as described previously (14) . Hearts were washed and finely minced in ice-cold isolation buffer containing 250 mM sucrose, 10 mM HEPES at pH 7.2, and 0.5 mM K ϩ -EGTA. The suspension was diluted threefold with isolation buffer supplemented with 1% fatty acid-free BSA. The time between decapitation and completion of homogenization was kept as brief as possible and was completed within 2 min; mitoK ATP activity shows a sharp dependence on the length of this period. The suspension was homogenized with a motorized Teflon pestle and centrifuged for 3 min at 1,500 g. The supernatant was centrifuged for 5 min at 9,000 g, and the resulting pellets were resuspended in isolation buffer lacking BSA and centrifuged for 3 min at 2,300 g. This supernatant was centrifuged for 5 min at 9,000 g. The final mitochondrial pellet was resuspended with isolation buffer to 35-40 mg protein/ml and kept on ice. Where indicated, rat liver mitochondria were isolated using a similar protocol, as previously described (5) . Mitochondrial protein concentration was estimated using the Biuret reaction (23) .
Measurements of mitoK ATP activity. MitoKATP opening causes mitochondrial swelling due to respiration-driven uptake of K ϩ salts and water. These volume changes were followed by light scattering, as previously described (5, 11, 14, 20) . Light-scattering changes of 0.1 mg/ml mitochondrial suspensions were followed at 520 nm and 30°C. Mitochondria were suspended in a buffered salt assay medium containing K ϩ salts of Cl Ϫ (120 mM), HEPES (10 mM), EGTA (0.1 mM), succinate (10 mM), MgCl2 (0.5 mM), phosphate (5 mM), ATP (200 M), rotenone (2.5 M), and oligomycin (1 g/ml) at pH 7.2. Osmolality ranged between 275 and 280 mosmol/kgH2O. Data summarized in bar graphs as "mitoKATP activity (%)" were calculated from
where A Ϫ1 (x) is the observed inverse absorbance at 120 s under the given experimental condition, and A Ϫ1 (ATP) and A Ϫ1 (0) are values independently measured in the presence and absence of ATP, respectively.
Preincubation protocol. A preincubation protocol was used to trigger activation of PKCε by endogenous ROS. As illustrated in Fig. 4 , mitochondria were incubated in the light-scattering assay medium (described above) for 3 min at 30°C with 30 M diazoxide. The preincubation medium was supplemented with various agents to explore the mechanisms of endogenous ROS signaling. Each sample was equally divided and preincubated in the presence or absence of diazoxide. The treated mitochondria were then isolated from the incubation medium and resuspended in a small volume (15 l) of ice-cold sucrose buffer containing 250 mM sucrose and 10 mM HEPES at pH 7.2. MitoK ATP activity of the treated mitochondria was then assayed using light scattering. When preincubated without diazoxide, the mitochondria behaved normally in the subsequent assay. That is, mitoK ATP activity was inhibited by ATP, and inhibition was released by diazoxide. When preincubated with diazoxide, mitoK ATP activity in the subsequent assay was not inhibited by ATP, and diazoxide had no effect. Thus, these conditions cause mitoKATP to remain open due to its phosphorylation by PKCε (13) . Any agent that blocks any step in the process will block feedback activation of mitoK ATP.
Measurements of MPT. MPT activity was monitored by light scattering in medium containing 200 M ATP and lacking EGTA. MPT opening was synchronized by sequential additions of CaCl 2 (100 M free Ca 2ϩ ), ruthenium red (0.1 M, to block further Ca 2ϩ uptake), and carbonyl cyanide m-chlorophenyl hydrazine (250 nM), at 20, 40, and 60 s, respectively (12) . These experiments used mitochondria from livers taken from the animals supplying the heart. Statistical analysis. Data are presented as means Ϯ SD. One-way ANOVA followed by Tukey's post hoc test or Student's t-test of the means was used as required to analyze the data using Microcal Origin software (Northampton, MA). A value of P Ͻ 0.05 was considered statistically significant.
Chemicals. Peroxynitrite was acquired from Cayman Chemical. All other chemicals were obtained from Sigma Chemical (St. Louis, MO). N-2-mercaptopropionylglycine (MPG) was always freshly prepared and adjusted to neutral pH by Tris base. Diazoxide and εV 1-2 were prepared in DMSO, and BEL was always freshly prepared in DMSO. Uric acid, Trolox, deferoxamine, catalase, 5-hydroxydecanoate (5-HD), and ruthenium red were prepared in distilled water. ATP . Feedback activation of mitoK ATP can be divided into three steps as described in Fig. 5 (21) , and the resulting K ϩ influx and matrix alkalinization leads to increased generation of superoxide (1).
RESULTS

Endogenous ROS signaling and PKC1-dependent feedback activation of mitoK
Step 2 encompasses the ROS transformations that result in formation of the signaling ROS, i.e., the ROS that activates PKCε1. In step 3, the activated PKCε1 establishes the phosphorylation dependent open state of mitoK ATP (13) . The rationale for this division is that we can study the effects of agents on the overall cycle and, independently, on steps 1 and 3. In this way, we can identify agents that interfere specifically with formation of the signaling ROS (step 2). Figure 6 contains results of control experiments using the preincubation protocol described in RESEARCH DESIGN AND METH-ODS. When mitochondria were preincubated with diazoxide and ATP, they exhibited maximum volume change in the normal assay medium containing ATP and no further effect was seen with the addition of diazoxide (1st 2 bars of Fig. 6 ). This result is characteristic of conditions that allow mitoK ATP to achieve the phosphorylation-dependent open state. When behaved as if there were no preincubation; that is, mitoK ATP activity was inhibited by ATP and opened by diazoxide. When step 3 was blocked by inclusion of the specific PKCε inhibitor εV 1-2 in the preincubation (last pair of bars), feedback activation was also prevented and mitoK ATP responded normally to ATP and diazoxide. Figure 7 contains results of preincubation experiments in which we evaluated agents that may block ROS signaling ( Step 2) in the feedback loop shown in Fig. 5 . DMSO, DMF, and MPG have all been described as reactants with HO˙, RȮ (alkoxyl radicals), and ROȮ (alkylperoxyl radicals; Refs. 2, 32), each of which may play a role in endogenous ROS signaling. Trolox, a vitamin E analog, acts as a chain-breaking antioxidant and peroxyl radical scavenger (31) . Figure 7A demonstrates that each of these agents prevented formation of the phosphorylation-dependent open state, suggesting that HOi s involved in the generation of the signaling ROS.
Deferoxamine is a chelator of iron (29, 41) and acts as a preventive antioxidant by reducing the rate of iron-dependent hydroxyl and peroxyl radical chain initiation. BEL (racemic bromoenol lactone) is an inhibitor of Ca 2ϩ -independent phospholipase (iPLA2; Ref. 8) , and it prevents the release of oxidized phospholipids such as hydroperoxy fatty acids (FAOOH) from the bilayer, a possible downstream oxidation product in the reaction sequence. Figure 7B shows that both deferoxamine and BEL blocked feedback activa- Step 1 of the process encompasses the sequence from opening to superoxide (O2 ·Ϫ ) formation. MitoKATP is opened by KATP channel openers such as Dzx (21) . Consequent uptake of K ϩ and anions leads to increased matrix volume (1Vol), which is the basis of the light-scattering assay for mitoKATP activity (14 
1).
Step 2 encompasses the many ROS transformations that take place and lead to the signaling ROS, which activates protein kinase-Cε1 (PKCε1). In step 3, the activated PKCε1 phosphorylates a protein, possibly mitoKATP itself, which leads to the phosphorylated open state of mitoKATP (13) . In parallel (not represented here), the ROS signal activates PKCε2, leading to inhibition of mitochondrial permeability transition (MPT) opening (12) . tion of mitoK ATP , further suggesting that hydroxyl radicals and their downstream oxidation products are involved in the generation of the signaling ROS. When uric acid, a peroxynitrite scavenger (44) , was included in the preincubation, the phosphorylation-dependent open state was preserved, indicating that peroxynitrite is not involved with any of the steps and, therefore, is not the signaling ROS. Catalase is an enzyme that catalyzes the decomposition of H 2 O 2 , and catalase was also unable to block this process, suggesting that H 2 O 2 is not the signaling ROS.
The mechanisms of action of these agents suggests that they are acting on step 2, the formation of the ROS signal; however, it is necessary to demonstrate that they are not acting elsewhere in the loop, i.e., on step 1 or step 3. Accordingly, we tested each of the agents for their effect on mitoK ATP activity in the straight light-scattering assay with no preincubation and found that none of them interfered with diazoxide opening of mitoK ATP (data not shown). Note that this assay also detects respiratory inhibition or uncoupling, which inhibit K ϩ uptake by reducing the driving force.
To evaluate their effect on step 3 (induction of the phosphorylated open state by PKCε1), we examined whether the agents were able to block mitoK ATP opening induced by H 2 O 2 , which works by activating PKCε1 (13) . Figure 8 contains representative light-scattering traces using mitochondria without preincubation. Here, we find that Trolox had no effect. MPG did block H 2 O 2 -induced mitoK ATP opening, which means that we cannot distinguish whether MPG acts on step 2 or step 3 from these experiments. The results of the step 3 assays are summarized in Fig. 9 and show that deferoxamine, DMSO, DMF, Trolox, and BEL did not inhibit H 2 O 2 -induced mitoK ATP opening (step 3). Because they also did not interfere with diazoxide opening of mitoK ATP (step 1), we infer that these agents are acting to prevent formation of the endogenous ROS signal that activates PKCε1 (step 2).
These findings may be summarized as follows. 1) Deferoxamine, DMSO, DMF, Trolox, and BEL each prevent formation of the endogenous ROS signal. These results imply that the ROS signal arises downstream from OḢ . 2) H 2 O 2 is produced upstream of OḢ , and catalase, the H 2 O 2 scavenger, had no effect on the formation of the phosphorylation-dependent open state. Therefore, H 2 O 2 can be excluded as the signaling ROS.
3) The action of MPG is independent of ROS scavenging. Like all thiols, MPG can scavenge OḢ , but OḢ is not involved in the pathway responsible for the results in Fig. 8 . Moreover, MPG has little or no H 2 O 2 scavenging ability (6, 30) . We propose that this action of MPG is due to its strong thiol reductant properties, holding PKCε in a reduced state and thereby preventing its activation.
Cardioprotection by ischemic preconditioning and diazoxide is blocked by DMF. The implication of the previous mitoK ATP experiments is that intercepting the HO˙-dependent reactions will block all modes of ROS-dependent cardioprotection. To examine this question, we perfused the heart with 1% DMF, the HO˙-scavenger, following the protocols described in Fig. 3 . As demonstrated in Fig. 10 , DMF inhibited the improvement in postischemic functional recovery (Fig.  10A ) and blocked the infarct-size reduction (Fig. 10B) normally observed with ischemic preconditioning and diazoxide. DMF alone had no effect on infarct size in these conditions (Fig. 10B) . Again, the effect of DMF on cardioprotective signaling implicates a downstream oxidation product of HO˙as the signaling ROS.
Endogenous ROS signaling and mitoK ATP -dependent MPT inhibition. MPT synchronization, described in RESEARCH DESIGN AND METHODS, was employed to determine the role of HO˙, RȮ , and/or ROȮ in diazoxide induced MPT inhibition, which depends on ROS activation of a second mitochondrial PKCε, PKCε2 (12) . Results of a representative experiment are contained in Fig. 11 . CsA completely blocked MPT activity, and diazoxide inhibited MPT opening by ϳ60%, which is the customary extent observed in these experiments (13) . This inhibition was reversed by 5-HD. MPG, DMSO, and DMF (not shown) also reversed MPT inhibition by diazoxide. These results also imply that the signaling ROS that activates PKCε2 must be a downstream oxidation product of HO˙. Fig. 9 . Effects of agents on activation of PKCε1 by H2O2. Agents that were utilized in the preincubation experiments of Fig. 6 were examined for their effects on H2O2-induced PKCε-dependent mitoKATP opening in the straight light-scattering assay described in RESEARCH DESIGN AND METHODS. MPG was the only agent that interfered with this step in the process. Deferoxamine, DMSO, DMF, Trolox, and BEL had no effect on H2O2 activation. Data are means of mitoKATP activity Ϯ SD of at least 3 independent experiments. ଙP Ͻ 0.05.
DISCUSSION
The major findings of the present study are 1) that the signaling ROS responsible for activating mitochondrial PKCεs is a downstream oxidation product of hydroxyl radical, not superoxide or H 2 O 2 ; and 2) that the main action of submillimolar MPG on mitochondria and perfused heart is inactivation of PKCε by thiol reduction rather than ROS scavenging.
MitoK ATP governs the ROS signaling that is essential for cardioprotection (18) . MitoK ATP opening has been found to increase levels of ROS in perfused heart (36), in cardiomyocytes (35) , and in the mitochondrial matrix (1). The ionophore valinomycin, at a concentration yielding the same K ϩ flux as diazoxide, caused the same ROS increase as diazoxide, so the mitoK ATP -dependent increase in ROS is due specifically to K ϩ influx into the matrix (1). The primary mitochondrial targets of ROS signaling are PKCε1, which activates mitoK ATP , and PKCε2, which inhibits MPT (reviewed in Ref. 19 ). Mitochondrial PKCε1 and mitoK ATP copurify and coreconstitute to form a functioning signaling module in proteoliposomes (25) . Thus mitoK ATP in either mitochondria or proteoliposomes can be opened by all PKCε activators, including phorbol esters, the specific peptide activator, ⌿εRACK, and a variety of thiol oxidizing agents.
Our objective is to identify the mitoK ATP -dependent endogenous ROS that activates PKCε1 to leave mitoK ATP in a phosphorylated open state. Superoxide is the first ROS that increases due to increased K ϩ uptake into the matrix (see Fig.  1 ) and has been proposed to be the ROS signal (38) . Xanthine/ xanthine oxidase (X/XO) induced mitoK ATP opening in isolated mitochondria; however, superoxide rapidly dismutates to H 2 O 2 in aqueous solution, and Costa et and Garlid (13) showed that X/XO did not open mitoK ATP in the presence of catalase. Therefore, the observed effect of X/XO was mediated by H 2 O 2 , and superoxide can be excluded as a PKCε activator or mitoK ATP opener. Queliconi et al. (38) (28) , which oxidize the thiols in the zinc finger of PKCε, leading to its activation. Consistent with this biochemistry, H 2 O 2 and NO cause mitoK ATP opening (13, 25) that is blocked by the PKCε peptide inhibitor εV 1-2 . The absence of an effect of H 2 O 2 and NO in the presence of εV [1] [2] demonstrates that these agents have no direct effect on mitoK ATP . Again, Queliconi et al. (38) repeated these experiments and obtained the same result; however, they failed to control for PKCε involvement and erroneously concluded that H 2 O 2 and NO open mitoK ATP directly.
Liu et al. (30) concluded that hydroxyl radical (HO˙) is responsible for ROS signaling in the heart, but this conclusion was based on experiments showing that MPG blocks ROS signaling and the assumption that this block was due to HOṡ cavenging. This assumption may be incorrect. The data in Fig.  8 show that MPG blocks H 2 O 2 -induced mitoK ATP opening. HO˙is not involved in this process, and MPG has little or no H 2 O 2 scavenging ability (6, 30) . Moreover, eliminating HOṙ equires very high concentrations of scavenger due to the transitory nature of HO˙, and it is unlikely that submillimolar concentrations of MPG would be effective. Thus most scavengers "will never be present at levels remotely approaching those of endogenous molecules that react at diffusion-controlled rates with HO˙" (24) . Therefore, we infer that MPG prevents signaling, not by scavenging ROS, but rather by virtue To investigate the location giving rise to the endogenous ROS signal, we employed the preincubation protocol described in RESEARCH DESIGN AND METHODS and RESULTS. This protocol leads to feedback activation of mitoK ATP , which depends on endogenous ROS signaling to PKCε1 (13) . The results of Figs. 4 -7 provide important clues to the identity of the ROS messenger. They are best understood in the context of Figs. 1 and  2 . The antioxidants deferoxamine and Trolox each prevented mitoK ATP opening. Deferoxamine is an iron chelator, and Trolox, a water soluble derivative of vitamin E, is a peroxyl radical scavenger and lipid peroxidation chain-breaking antioxidant. These data indicate that the redox-sensitive opening of mitoK ATP is dependent on both iron and peroxyl radicals and are consistent with transition metal-catalyzed ROȮ -dependent signaling. These steps occur downstream of HO˙production and strongly suggest that HO˙is the precursor of the signaling molecule. This is supported by the finding that inclusion of DMSO or DMF, which react with HO˙, RȮ , and/or ROȮ (2), in the preincubation prevented mitoK ATP opening.
Many workers have proposed that H 2 O 2 is the messenger of ROS-dependent mitoK ATP opening (1, 46) . H 2 O 2 would appear to be a good candidate, not the least because it is effective in activating mitochondrial PKCε (11, 13, 25, 50) and in protecting ischemic heart (47, 49) and hypoxic cardiomyocytes (16). However, a major finding of the present study is that H 2 O 2 can be excluded as the signaling ROS in mitochondria and that the signaling ROS originates downstream of hydroxyl radical. The evidence is 1) the ROS signal arises downstream from OḢ radical, whereas H 2 O 2 is produced upstream of OḢ radical (Fig.  1) ; and 2) catalase, the H 2 O 2 scavenger, had no effect on the formation of the phosphorylation-dependent open state, whereas DMF and DMSO, which have neither H 2 O 2 scavenging nor thiol reductant properties, do block PKCε-dependent mitoK ATP activation. Circumstantial evidence also argues against H 2 O 2 as the signaling ROS: H 2 O 2 is produced in the matrix, whereas PKCε1 faces the intermembrane space. The matrix of heart mitochondria contains glutathione, thioredoxin reductase, and catalase, which may prevent sufficient H 2 O 2 from reaching its target (42) .
The conclusion that the ROS message is formed downstream from HO˙is further supported by the effects of DMSO and DMF on endogenous ROS-dependent MPT inhibition (Fig.  10) . Finally, the finding that DMF prevents cardioprotection by both ischemic preconditioning and diazoxide (Fig. 11) supports extension of the conclusion to the ex vivo and in vivo heart. That HO˙is necessary for cardioprotective signaling should not be taken to mean that HO˙itself is the signaling ROS. HO˙is too reactive for signaling, with a half-life that is diffusion limited at ϳ1 ns (24) . HO˙will react with its nearest neighbors almost immediately after it is formed, allowing for the formation of downstream oxidation products that are most likely responsible for signaling.
Finally, the finding that BEL interrupted the ROS signal (Fig. 7) implicates hydroperoxy fatty acids (FAOOH) as the ROS signal. A full investigation of the effects of fatty acids and hydroperoxy fatty acids on mitoK ATP and on ischemia-reperfusion injury will be presented in a subsequent communication.
Limitations. 1)
The conclusions are based largely on in vitro experiments carried out on isolated mitochondria. The rationale for this approach is that the signaling ROS not only originates in mitochondria but also acts on mitochondria. We have no reason to believe that the ROS transformation reaction sequence is any different in vivo. 2) We stress that the conclusions relate specifically to ROS signaling secondary to mitoK ATP opening. The reverse sequence, mitoK ATP opening caused by ROS, may also be physiologically important. For example, it is possible that the increased ROS that occurs during ischemia opens mitoK ATP , and this ROS may arise from a different location, such as complex III. The identity of the ROS signal in this setting has not yet been addressed. 3) BEL has been shown to inhibit activation of store-activated Ca 2ϩ channels; however, this is mediated by inhibition of iPLA2 and is therefore a pharmacological effect (40) . It has recently been shown that BEL inhibits voltage-gated Ca 2ϩ and transient receptor potential canonical channels independently of iPLA2 (9) . We consider it unlikely that these effects play a role in the effect of BEL on isolated mitochondria.
Conclusions and potential conceptual/pragmatic values of these findings. We conclude that the signaling ROS responsible for activating mitochondrial PKCεs is a downstream oxidation product of hydroxyl radical and that superoxide and H 2 O 2 are not the signaling ROS. We further conclude that the main action of submillimolar MPG on mitochondria and perfused heart is not ROS scavenging but rather thiol reduction, causing inactivation of PKCε and other ROS-dependent kinases. MitoK ATP -dependent ROS signaling is a central process in cardioprotection and cellular signaling generally. Determining the identity of the mitochondrial signaling ROS is important for future research in these areas.
